![CAS No 39713-40-1 7,8-dihydro-5H-cyclohepta[b]pyridine-5,9(6H)-dione Pharmaceutical Intermediates](https://ecdn6.globalso.com/upload/p/2209/image_other/2025-04/39713-40-1-7-8-dihydro-5h-cyclohepta-b-pyridine-5-9-6h-dione-structural-formula.png)
0102030405
Acalabrutinib Intermediate CAS No.1420478-90-5 Pharmaceutical Intermediates
02
Introduction to Acalabrutinib Intermediate
7 Jan 2019
Acalabrutinib Intermediate is a crucial chemical compound used in the synthesis of Acalabrutinib, a potent and selective Bruton's tyrosine kinase (BTK) inhibitor. As an integrated manufacturing and trading factory, we ensure the highest standards of quality and reliability in the production and supply of this essential intermediate. Our commitment to excellence and customer satisfaction makes us a trusted partner for pharmaceutical companies worldwide.
02
Physical and Chemical Properties
7 Jan 2019
Acalabrutinib Intermediate, with the molecular formula C26H23N7O2, is a white to off-white crystalline powder. It has a molecular weight of 465.51 g/mol. The compound exhibits excellent stability under standard storage conditions, ensuring a long shelf life and consistent performance in various applications.
- Molecular Formula: C26H23N7O2
- Molecular Weight: 465.51 g/mol
- Appearance: White to off-white crystalline powder
- Melting Point: 220-225°C
- Solubility: Soluble in DMSO, ethanol, and other organic solvents
1. High Purity and Consistent Quality: Our Acalabrutinib Intermediate is produced using advanced manufacturing techniques, ensuring a high degree of purity and consistent quality. This makes it ideal for use in sensitive pharmaceutical applications.
2. Reliable Supply: As an integrated manufacturing and trading factory, we have complete control over the production process, from raw material procurement to final product delivery. This ensures a reliable and uninterrupted supply of Acalabrutinib Intermediate to our customers.
3. Superior Stability: The compound's excellent physical and chemical stability ensures that it remains effective and reliable throughout its shelf life, providing consistent results in pharmaceutical formulations.
4. Competitive Pricing: Our efficient production processes and economies of scale allow us to offer Acalabrutinib Intermediate at competitive prices, providing excellent value for our customers.
5. Exceptional Customer Support: We pride ourselves on our customer-centric approach, offering comprehensive support and technical assistance to ensure the successful application of our products in your pharmaceutical projects.
Acalabrutinib Intermediate is a crucial component in the synthesis of Acalabrutinib, a targeted cancer therapy used to treat various types of B-cell malignancies such as chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL). Its unique chemical structure and reactivity make it an essential building block for the development of novel drugs and therapeutic agents.
- Targeted Cancer Therapies: Acalabrutinib Intermediate is a key component in the development of targeted cancer therapies, providing effective treatment options for patients with B-cell malignancies.
- Combination Therapies: The compound is utilized in combination with other therapeutic agents to enhance the efficacy of cancer treatments and improve patient outcomes.
- Clinical Research: Acalabrutinib Intermediate is extensively used in clinical research to explore new therapeutic applications and improve existing treatment protocols for various types of cancer.
Acalabrutinib Intermediate is an indispensable component in the pharmaceutical industry, offering high purity, superior stability, and reliable performance. As an integrated manufacturing and trading factory, we are committed to providing our customers with the highest quality products and unparalleled support. Partner with us for your pharmaceutical synthesis needs and experience the benefits of our expertise and dedication to excellence.